View in EDS

Off-label use of prasugrel in stable coronary artery disease is associated with greater degree of platelet inhibition compared with use after acute coronary syndrome.

Saved in:
Bibliographic Details
Title: Off-label use of prasugrel in stable coronary artery disease is associated with greater degree of platelet inhibition compared with use after acute coronary syndrome.
Authors: Cuisset, Thomas1,2,3 thomas.cuisset@ap-hm.fr, Cayla, Guillaume4, Quilici, Jacques1,2,3, Pankert, Mathieu1,2,3, Deharo, Pierre1,2,3, Bonnet, Guillaume1,2,3, Grosdidier, Charlotte2,3,5, Beguin, Shirley6, Morange, Pierre2,3,5, Bonnet, Jean-Louis1,2,3, Alessi, Marie-Christine2,3,5
Source: International Journal of Cardiology. Oct2013, Vol. 168 Issue 3, p2988-2989. 2p.
Database: Academic Search Ultimate
Description
ISSN:01675273
DOI:10.1016/j.ijcard.2013.04.052